retatrutide nejm 2023 obesity trial ly3437943 Medscape | The investigational triple GLP-1/GIP/glucagon receptor agonist produced significant weight loss and A1c reduction in people Retatrutide Phase 3: TRIUMPH Program

Consequently, people who start taking GLP-1s may find themselves consuming a lot fewer calories than they had been before

Actively studied in Phase 2/3 trials and a major object of incretin literature

Curcumin may prevent critical COVID-19 by blocking ACE2 production (necessary for viral entry) and stimulating anticoagulation and fibrinolysis (425)

Metabolic alterations have often been found in cancer cells, as cancer cells have a higher demand for ATP and other metabolites to sustain their unlimited proliferation and growth, and the higher metabolic activity in cells would lead to more ROS generation due to more mitochondria respiration

The harmful compound in the mould that caused the bleeding, called dicoumarol, was eventually developed into warfarin

Writing original draft: Hani Haytham Mawardi, Ali Anwar Aboalola, Thamer Abdulmohsin Al-Ghalib, Rawah Talal Eshky, Adham Abdulmajeed Niyazi, Mohammed Haytham Mawardi